Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 102 The United Laboratories International Holdings Limited Annual Report 2022 13. DIRECTORS’ AND CHIEF EXECUTIVE’S EMOLUMENTS Directors’ and chief executive’s remuneration for the year, disclosed pursuant to the applicable Listing Rules and Hong Kong Companies Ordinance, is as follows: 2022 (a) Executive directors Tsoi Leung Choy Fang Zou Zhu Hoi Shan Wing Hon Siu Chit Yu Ping Xian Hong Su Yan Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 (Note) Fees – – – – – – – Other emoluments Salaries and other benefits 3,983 3,858 2,645 1,711 1,711 1,711 15,619 Bonus – 105 – 720 720 720 2,265 Contributions to retirement benefit schemes 16 16 16 41 – – 89 Sub-total 3,999 3,979 2,661 2,472 2,431 2,431 17,973 Note: Tsoi Hoi Shan is the chief executive director and chairman of the Company for the years ended 31 December 2022 and 2021. The executive directors’ emoluments shown above were for their services in connection with the management of the affairs of the Company and the Group. (b) Independent non-executive directors Chong Song Fu Peng Oon Ming Xiao Nan Total RMB’000 RMB’000 RMB’000 RMB’000 Fees 222 222 222 666 The independent non-executive directors’ emoluments shown above were for their services as directors of the Company. Total 18,639